Rezultati

eNauka >  Results >  Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study
Title: Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study
Authors Tan, Antoinette R; Wright, Gail; Thummala, Anu; Danso, Michael; Popovic, Lazar S  ; Pluard, Timothy; ...et al.; Milenkovic, Dusan M; (broj, koautora 17)
Issue Date: 2022
Publication: CLINICAL CANCER RESEARCH
ISSN: 1078-0432 Clinical Cancer Research Search Idenfier
Type: Article
Collation: vol. 28 br. 4 str. 629-636
DOI: 10.1158/1078-0432.CCR-21-2272
WoS-ID: 000756658800001
Scopus-ID: 2-s2.0-85124961817
PMID: 34887261
PMCID: PMC9377748
URI: https://enauka.gov.rs/handle/123456789/802379
Project: G1 Therapeutics, Inc.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

41
SCOPUSTM
20
PubMed CentralTM
4
OpenCitations
36
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.